Interaction System of the State and Business in the Regime of Public-Private Partnership in the Pharmaceutical Complex of the Russian Federation

Abstract

The issue of interaction between the state and business in the mode of public-private partnership in the pharmaceutical complex of the Russian Federation is investigated. The concept of "state" and "business" is defined, the forms of interaction between the state and business are considered, the concept of "public-private partnership" is defined, the main features of public-private partnership in general and in the pharmaceutical complex in particular are identified, the goals and investments of partners in public-private partnership in the pharmaceutical sector, studied the prospects for the development of public-private partnership in the pharmaceutical sector of the country as a form of interaction between the state and business. The researcher also researched economic, legal and organizational partnership. One of the types of economic partnership in this area of activity is а public-private partnership. Public-private partnership in the pharmaceutical sector of the Russian Federation is а cooperation for a specified period between the state and the private sector on the basis of which, by combining the experience and expertise of the state and business, sharing financial risks and benefits, socially significant programs and projects in the pharmaceutical sector is implemented. It has been established that the subjects of interaction between business and the state in the form of public-private partnership are public and private partners, who, when participating in this type of interaction, set different goals and play different roles. It has been revealed that this type of partnership has great development prospects, which will contribute to increasing the competitiveness of the pharmaceutical sector, modernizing the health care system, improving the quality of health services delivery and access to medicines. The development of public-private partnerships as a form of interaction between the state and business in the pharmaceutical sector is an effective mechanism for the modernization of the industrial national sector.